Skip to main content

Table 2 Baseline characteristics of febrile children with uncomplicated falciparum malaria enrolled in artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) groups

From: Malaria burden and anti-malarial drug efficacy in Owando, northern Congo

Characteristics

Treatment group

ASAQ

AL

No. of included patients

62

61

Age (months), mean ± SD (range)

71.0 ± 31.8 (9–132)

57.3 ± 30.4 (6–132)

<60 months (<5 years): N; % (95 % CI)

19; 30.6 (19.6–43.7)

29; 47.5 (34.6–60.7)

60–132 months (5–11 years): N; % (95 % CI)

43; 69.4 (56.3–80.4)

32; 52.5 (39.3–65.4)

Weight (kg), mean ± SD (range)

19.9 ± 7.8 (9–57)

18.1 ± 7.8 (7–44)

Sex ratio (F/M)

0.94 (30/32)

1.26 (34/27)

Axillary temperature, mean ± SD (range) (°C)

37.9 ± 1.0 (36.0–40.0)

38.0 ± 1.0 (36.0–40.4)

Parasite density (asexual parasites/µL)

 Geometric mean (range)

37,600 (1550–955,000)

34,200 (1000–700,000)

Self-medication before consultation: N; % (95 % CI)

0; 0 (0–5.8)

3; 4.9 (1.0–13.7)

Haematocrit, mean ± SD (%)

32.9 ± 5.0

31.9 ± 5.4

  1. There was a significant difference (p = 0.01) in age between the two treatment groups
  2. SD standard deviation, 95 % CI 95 % confidence interval